Liuting Chen

Nantong, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Fueling Disease: ACSS2 in Obesity-Associated Metabolic Disorders and Cancer Progression.

Fueling Disease: ACSS2 in Obesity-Associated Metabolic Disorders and Cancer Progression.

Journal: Obesity reviews : an official journal of the International Association for the Study of Obesity

Published: June 17, 2025

N4BP1 is essential for the development of oral cancer via controlling both cancer cells and immune microenvironment.

N4BP1 is essential for the development of oral cancer via controlling both cancer cells and immune microenvironment.

Journal: Cell death & disease

Published: May 20, 2025

Cytoplasmic Accumulation of Histones Induced by BET Inhibition Protects Cells from C9orf72 Poly(PR)-Induced Cell Death.

Cytoplasmic Accumulation of Histones Induced by BET Inhibition Protects Cells from C9orf72 Poly(PR)-Induced Cell Death.

Journal: Advanced biology

Published: July 14, 2023

BRD4 inhibitors broadly promote erastin-induced ferroptosis in different cell lines by targeting ROS and FSP1.

BRD4 inhibitors broadly promote erastin-induced ferroptosis in different cell lines by targeting ROS and FSP1.

Journal: Discover oncology

Published: July 02, 2023

Identifying a locus in super-enhancer and its resident NFE2L1/MAFG as transcriptional factors that drive PD-L1 expression and immune evasion.

Identifying a locus in super-enhancer and its resident NFE2L1/MAFG as transcriptional factors that drive PD-L1 expression and immune evasion.

Journal: Oncogenesis

Published: May 13, 2023

N4BP1 regulates keratinocytes development and plays protective role in burn- and adhesive-related skin injury via MMP9.

N4BP1 regulates keratinocytes development and plays protective role in burn- and adhesive-related skin injury via MMP9.

Journal: Cellular signalling

Published: February 23, 2023

rSjP40 Inhibited the Activity of Collagen Type I Promoter via Ets-1 in HSCs.

rSjP40 Inhibited the Activity of Collagen Type I Promoter via Ets-1 in HSCs.

Journal: Frontiers in cell and developmental biology

Published: August 27, 2021

Toxoplasma gondii excreted-secreted antigens suppress Foxp3 promoter activity via a SP1-dependent mechanism.

Toxoplasma gondii excreted-secreted antigens suppress Foxp3 promoter activity via a SP1-dependent mechanism.

Journal: Journal of cellular and molecular medicine

Published: April 20, 2020

Selenoprotein P inhibits cell proliferation and ROX production in HCC cells.

Selenoprotein P inhibits cell proliferation and ROX production in HCC cells.

Journal: PloS one

Published: December 26, 2019

rSjp40 inhibits activated hepatic stellate cells by promoting nuclear translocation of YB1 and inducing BMP-7/Smad1/5/8 pathway.

rSjp40 inhibits activated hepatic stellate cells by promoting nuclear translocation of YB1 and inducing BMP-7/Smad1/5/8 pathway.

Journal: Parasites & vectors

Published: March 13, 2019

rSJYB1 inhibits collagen type I protein expression in hepatic stellate cells via down-regulating activity of collagen α1 (I) promoter.

rSJYB1 inhibits collagen type I protein expression in hepatic stellate cells via down-regulating activity of collagen α1 (I) promoter.

Journal: Journal of cellular and molecular medicine

Published: December 21, 2018

Toxoplasma gondii excreted-secreted antigens suppress Foxp3 via PI3K-AKT-mTOR signaling pathway.

Toxoplasma gondii excreted-secreted antigens suppress Foxp3 via PI3K-AKT-mTOR signaling pathway.

Journal: Journal of cellular biochemistry

Published: September 27, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026